Pennsylvania Trust Co lessened its position in Balchem Co. (NASDAQ:BCPC) by 88.7% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,705 shares of the basic materials company’s stock after selling 37,040 shares during the period. Pennsylvania Trust Co’s holdings in Balchem were worth $369,000 as of its most recent filing with the SEC.
Other large investors have also recently modified their holdings of the company. First Hawaiian Bank increased its stake in Balchem by 68.0% in the first quarter. First Hawaiian Bank now owns 378 shares of the basic materials company’s stock valued at $35,000 after purchasing an additional 153 shares in the last quarter. NumerixS Investment Technologies Inc bought a new stake in Balchem in the fourth quarter valued at approximately $39,000. Pearl River Capital LLC bought a new stake in Balchem in the fourth quarter valued at approximately $45,000. Bank of Montreal Can increased its stake in Balchem by 13.6% in the fourth quarter. Bank of Montreal Can now owns 1,926 shares of the basic materials company’s stock valued at $151,000 after purchasing an additional 231 shares in the last quarter. Finally, Quantamental Technologies LLC bought a new stake in Balchem in the fourth quarter valued at approximately $188,000. 87.80% of the stock is owned by hedge funds and other institutional investors.
Shares of BCPC stock opened at $97.98 on Monday. The company has a quick ratio of 1.94, a current ratio of 2.76 and a debt-to-equity ratio of 0.24. Balchem Co. has a 12-month low of $73.16 and a 12-month high of $117.79. The firm has a market cap of $3.16 billion, a PE ratio of 32.55 and a beta of 1.00.
BCPC has been the subject of several recent analyst reports. HC Wainwright set a $101.00 target price on shares of Balchem and gave the company a “buy” rating in a research note on Tuesday, February 5th. Zacks Investment Research downgraded shares of Balchem from a “buy” rating to a “hold” rating in a research note on Monday, February 18th. Seaport Global Securities initiated coverage on shares of Balchem in a research note on Thursday, February 21st. They issued a “neutral” rating for the company. Finally, BidaskClub raised shares of Balchem from a “sell” rating to a “hold” rating in a research note on Wednesday, February 20th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and three have given a buy rating to the stock. Balchem presently has a consensus rating of “Hold” and an average price target of $105.50.
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization, and industrial markets in the United States and internationally. The company's Human Nutrition & Health segment supplies ingredients in the food and beverage industry.
Further Reading: Different Options Trading Strategies
Want to see what other hedge funds are holding BCPC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Balchem Co. (NASDAQ:BCPC).
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.